À¯¿µ°æ ¸íÀÇ

°£∙´ã∙Ãé¼ö¼ú 000·Ê ÀÌ»ó, °£ÀÌ½Ä 700·Ê ÀÌ»ó

À¯¿µ°æ ¸íÀÇ

  • ¼Ò ¼Ó
    °¡Å縯´ë¼­¿ï¼º¸ðº´¿ø °£´ãÃé¿Ü°ú
  • Àü¹®ºÐ¾ß
    °£À̽Ä, °£¡¤´ã¡¤Ãé Áúȯ, º¹°­°æ¼ö¼ú, ·Îº¿¼ö¼ú

ÁÖ¿ä Áø·á ºÐ¾ß´Â °£À̽Ä, °£¡¤´ã¡¤ÃéÁúȯ, º¹°­°æ¼ö¼úÀÌ´Ù. 2007³â ÀÌÈÄ 3000·Ê ÀÌ»óÀÇ °£¡¤´ã¡¤Ãé ¼ö¼ú ¹× 700·Ê ÀÌ»óÀÇ °£ÀÌ½Ä ¼ö¼úÀ» ÁýµµÇß´Ù.
´ÜÀÏÅë·Î(½Ì±ÛÆ÷Æ®) º¹°­°æ ½Ã¼ú¹ýÀ¸·Î °£ ÀýÁ¦ 300¿©°ÇÀ» ½ÃÇàÇØ ±¹³» ÃÖ´Ù ±â·ÏÀ» °¡Áö°í ÀÖ´Ù.

¸íÀÇÇÁ·ÎÇÊ ¸íÀÇ ÇÁ·ÎÇÊ

ÇзÂ

Educational Background
  • °¡Å縯´ë ÀÇ´ë Çлç
  • °¡Å縯´ë ÀÇ´ë ¼®»ç
  • °¡Å縯´ë ÀÇ´ë ¹Ú»ç
  • ÀϺ» ±³Åä´ëÇб³ À̽Ŀܰú °£ÀÌ½Ä ¿¬¼ö (2001 ~ 2002)
  • ¿µ±¹ ·±´ø King's College Hospital, Liver Unit (2001)

ÁÖ¿ä°æ·Â

Work Experience
  • úÞ) °¡Å縯´ëÇб³ ¼­¿ï¼º¸ðº´¿ø ¿Ü°ú ±³¼ö
  • úÞ) ´ëÇÑ °£ÀÌ½Ä ¿¬±¸ÇÐȸ ȸÀå
  • °¡Å縯´ëÇб³ ¼­¿ï¼º¸ðº´¿ø °£´ãÃé¾Ï¼¾ÅÍÀå (2017 ~ 2019)

ÇÐȸȰµ¿

Academic activities
  • 2011 ~ ÇöÀç´ëÇÑÀ̽ÄÇÐȸ ÀÌ»ç
  • 2010 ~ ÇöÀç´ëÇѿܰúÇÐȸ ÆòÀÇ¿ø
  • 2012 ~ 2014´ëÇѳ»½Ã°æº¹°­°æ¿Ü°úÇÐȸ ÀÌ»ç
  • 2012 ~ 2014´ëÇѰ£À̽Ŀ¬±¸È¸ Ãѹ«
  • 2010 ~ 2012´ëÇѳ»½Ã°æº¹°­°æ¿Ü°úÇÐȸ Ãѹ«ÀÌ»ç
  • 2010 ~ 2012´ëÇѿܰú´ë»ç¿µ¾çÇÐȸ ÇмúÀ§¿ø
Àú¼­ ¾ÆÀÌÄÜ

ÁýÇÊÀú¼­

ÃÑ 0°Ç
¿¬±¸ ¾ÆÀÌÄÜ

ÁÖ¿ä³í¹®

ÃÑ 5°Ç
Á¦ ¸ñ Isolation and characterization of cancer-associated fibroblasts in the tumor microenvironment of hepatocellular carcinoma
¹ßÇ¥³âµµ 2023 ¹ßÇ¥Áö ´ëÇѰ£¾ÏÇÐȸÁö (JOURNAL OF LIVER CANCER)
Á¦ ¸ñ Clinical significance of preoperative antibiotic use in mild to moderate acute inflammatory gallbladder disease: A randomized controlled trial
¹ßÇ¥³âµµ 2023 ¹ßÇ¥Áö JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES
Á¦ ¸ñ Induction of liver transplant immune tolerance in an outbred rat strain model using tacrolimus
¹ßÇ¥³âµµ 2023 ¹ßÇ¥Áö LABORATORY ANIMAL RESEARCH
Á¦ ¸ñ Long-term Clinical Outcomes and Predictive Factors for Living-donor Liver Transplant Recipients With Biliary Strictures
¹ßÇ¥³âµµ 2022 ¹ßÇ¥Áö TRANSPLANTATION
Á¦ ¸ñ Clinical significance of preoperative antibiotic use in mild to moderate acute inflammatory gallbladder disease: A randomized controlled trial
¹ßÇ¥³âµµ 2022 ¹ßÇ¥Áö JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES

¸íÀÇqna ¸íÀÇ ¼Ò¼Óº´¿ø

°¡Å縯´ë¼­¿ï¼º¸ðº´¿ø

»ó±ÞÁ¾ÇÕº´¿ø
ÀüÈ­ ¾ÆÀÌÄÜ ´ëÇ¥¹øÈ£
1588-1511
À¥»çÀÌÆ® ¾ÆÀÌÄÜȨÆäÀÌÁö

ÁÖ¿ä½Ã¼³

ÀÀ±Þ½Ç ÀÀ±Þ½Ç
Ŭ¸®´Ð Ŭ¸®´Ð
Á¾ÇÕ°ËÁø¼¾ÅÍ Á¾ÇÕ°ËÁø¼¾ÅÍ
¾Ï¼¾ÅÍ ¾Ï¼¾ÅÍ
ÁÖÂ÷½Ã¼³ ÁÖÂ÷½Ã¼³

°¡Å縯´ë¼­¿ï¼º¸ðº´¿øÀº 1980³â °­³² Áö¿ª ÃÖÃÊÀÇ Á¾ÇÕº´¿øÀ¸·Î ¼¼¿öÁ³´Ù. ÇöÀç Áö»ó 22Ãþ, ÁöÇÏ 6ÃþÀÇ 1355º´»ó ±Ô¸ð¸¦ °®Ãß°í ÀÖÀ¸¸ç ´ÜÀÏ °Ç¹° º´¿øÀ¸·Î´Â ±¹³» ÃÖ´ë ±Ô¸ðÀÌ´Ù. °¡Å縯´ë¼­¿ï¼º¸ðº´¿øÀº °¡Å縯±³È¸ÀÇ ´ëÇ¥ º´¿øÀ¸·Î °¡Å縯Áß¾ÓÀÇ·á¿øÀÇ ÀÌ³ä ½Çõ¿¡ Àû±Ø ¾ÕÀå¼­°í ÀÖÀ¸¸ç, ȯÀÚ¸¦ ¸ÕÀú »ý°¢ÇÏ´Â Àü¹®¼¾ÅÍ Áß½ÉÀÇ º´¿ø, 21¼¼±â ÃÖ÷´Ü ÀÇ·á ½Ã½ºÅÛ º´¿øÀ¸·Î °Åµì³ª°í ÀÖ´Ù.

°¡Å縯´ë¼­¿ï¼º¸ðº´¿ø À̹ÌÁö

¼­¿ïƯº°½Ã ¼­Ãʱ¸ ¹ÝÆ÷´ë·Î 222

Ȩ
³»°¡ ¾Ë°íÀÖ´Â ¸íÀǸ¦ ÃßÃµÇØÁÖ¼¼¿ä